Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-01
2005-03-01
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252060, C514S255050, C514S256000, C514S292000, C544S238000, C544S333000, C544S405000, C546S085000
Reexamination Certificate
active
06861430
ABSTRACT:
The invention provides compounds of formula (I) wherein R1 to R5 are as defined in the description, and their preparation. The compounds of formula (I) are useful as pharmaceuticals.
REFERENCES:
patent: 5348958 (1994-09-01), Kruger et al.
patent: 6057340 (2000-05-01), Kelly et al.
patent: WO 9964420 (1999-12-01), None
Poitout L. et al., “Identification of Potent Non-Peptide Somatostatin Antagonists with sst3Selectivity”, J. Med. Chem.,vol. 44, pp. 2990-3000 (2001).
Hoyer Daniel
Hurth Konstanze
Troxler Thomas J.
Novartis AG
Rao Deepak
Wiusz, Jr. E. Jay
LandOfFree
β-carboline derivatives and its pharmaceutical use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with β-carboline derivatives and its pharmaceutical use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β-carboline derivatives and its pharmaceutical use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3374371